nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—Purine metabolism—CAT—psoriasis	0.0132	0.122	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—CAT—psoriasis	0.00665	0.0611	CbGpPWpGaD
Nelarabine—POLA1—Leading Strand Synthesis—PCNA—psoriasis	0.00508	0.0466	CbGpPWpGaD
Nelarabine—POLA1—Removal of the Flap Intermediate—PCNA—psoriasis	0.00508	0.0466	CbGpPWpGaD
Nelarabine—POLA1—Processive synthesis on the lagging strand—PCNA—psoriasis	0.00457	0.0419	CbGpPWpGaD
Nelarabine—ADA—Purine metabolism—CAT—psoriasis	0.0044	0.0403	CbGpPWpGaD
Nelarabine—POLA1—G1/S-Specific Transcription—PCNA—psoriasis	0.00435	0.0399	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—CAT—psoriasis	0.00406	0.0372	CbGpPWpGaD
Nelarabine—POLA1—Lagging Strand Synthesis—PCNA—psoriasis	0.00367	0.0337	CbGpPWpGaD
Nelarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—psoriasis	0.00342	0.0313	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—VDR—psoriasis	0.00322	0.0295	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—VDR—psoriasis	0.00288	0.0264	CbGpPWpGaD
Nelarabine—POLA1—Extension of Telomeres—PCNA—psoriasis	0.00284	0.026	CbGpPWpGaD
Nelarabine—POLA1—DNA strand elongation—PCNA—psoriasis	0.00262	0.0241	CbGpPWpGaD
Nelarabine—POLA1—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.00256	0.0235	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NDUFA5—psoriasis	0.00237	0.0217	CbGpPWpGaD
Nelarabine—ADA—Nucleotide metabolism—CAT—psoriasis	0.00221	0.0203	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—PCNA—psoriasis	0.00211	0.0194	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—CAT—psoriasis	0.00204	0.0187	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2S1—psoriasis	0.00201	0.0185	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Clobetasol propionate—psoriasis	0.00186	0.0833	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Clobetasol propionate—psoriasis	0.00181	0.0809	CbGdCrCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.00161	0.0148	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.00154	0.0141	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Beclomethasone—psoriasis	0.00149	0.0667	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Fluocinonide—psoriasis	0.00149	0.0667	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.00145	0.0649	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Beclomethasone—psoriasis	0.00145	0.0648	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Fluocinonide—psoriasis	0.00145	0.0648	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Fluocinolone Acetonide—psoriasis	0.00141	0.0629	CbGdCrCtD
Nelarabine—POLA1—Norethindrone—Hydrocortisone—psoriasis	0.00131	0.0584	CbGdCrCtD
Nelarabine—POLA1—Telomere Maintenance—PCNA—psoriasis	0.00129	0.0118	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.00118	0.0108	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—CD4—psoriasis	0.00112	0.0102	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—PCNA—psoriasis	0.00109	0.00999	CbGpPWpGaD
Nelarabine—POLA1—Chromosome Maintenance—PCNA—psoriasis	0.00107	0.00983	CbGpPWpGaD
Nelarabine—POLA1—Levonorgestrel—Hydrocortisone—psoriasis	0.00104	0.0464	CbGdCrCtD
Nelarabine—POLA1—DNA Replication—PCNA—psoriasis	0.00102	0.00937	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PTTG1—psoriasis	0.000997	0.00915	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—PCNA—psoriasis	0.000984	0.00903	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CARM1—psoriasis	0.000983	0.00902	CbGpPWpGaD
Nelarabine—POLA1—S Phase—PCNA—psoriasis	0.000893	0.0082	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000829	0.00761	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—LEP—psoriasis	0.000805	0.00739	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NDUFA5—psoriasis	0.000786	0.00721	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NOS2—psoriasis	0.00075	0.00688	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000746	0.00685	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Hydrocortisone—psoriasis	0.000733	0.0328	CbGdCrCtD
Nelarabine—DCK—Metabolism—NDUFA5—psoriasis	0.000725	0.00665	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PPARG—psoriasis	0.000701	0.00643	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Dexamethasone—psoriasis	0.000681	0.0304	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Betamethasone—psoriasis	0.000681	0.0304	CbGdCrCtD
Nelarabine—ADA—Metabolism—CYP2S1—psoriasis	0.000668	0.00613	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PTTG1—psoriasis	0.000667	0.00612	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Triamcinolone—psoriasis	0.000665	0.0297	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Betamethasone—psoriasis	0.000661	0.0295	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Dexamethasone—psoriasis	0.000661	0.0295	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Triamcinolone—psoriasis	0.000646	0.0288	CbGdCrCtD
Nelarabine—DCK—Desoximetasone—Prednisone—psoriasis	0.000631	0.0282	CbGdCrCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000628	0.00576	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2S1—psoriasis	0.000616	0.00566	CbGpPWpGaD
Nelarabine—DCK—Desoximetasone—Prednisolone—psoriasis	0.000616	0.0275	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Prednisone—psoriasis	0.000613	0.0274	CbGdCrCtD
Nelarabine—DGUOK—Metabolism—CAT—psoriasis	0.000604	0.00555	CbGpPWpGaD
Nelarabine—DCK—Diflorasone—Prednisolone—psoriasis	0.000598	0.0267	CbGdCrCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000592	0.00543	CbGpPWpGaD
Nelarabine—Loss of consciousness—Prednisolone—psoriasis	0.000589	0.000678	CcSEcCtD
Nelarabine—Thrombocytopenia—Cyclosporine—psoriasis	0.000588	0.000677	CcSEcCtD
Nelarabine—Body temperature increased—Mycophenolic acid—psoriasis	0.000587	0.000676	CcSEcCtD
Nelarabine—Abdominal pain—Mycophenolic acid—psoriasis	0.000587	0.000676	CcSEcCtD
Nelarabine—Dizziness—Hydroxyurea—psoriasis	0.000586	0.000675	CcSEcCtD
Nelarabine—Oedema—Mycophenolate mofetil—psoriasis	0.000586	0.000674	CcSEcCtD
Nelarabine—Angiopathy—Betamethasone—psoriasis	0.000582	0.00067	CcSEcCtD
Nelarabine—Angiopathy—Dexamethasone—psoriasis	0.000582	0.00067	CcSEcCtD
Nelarabine—Infection—Mycophenolate mofetil—psoriasis	0.000582	0.00067	CcSEcCtD
Nelarabine—Convulsion—Prednisolone—psoriasis	0.00058	0.000668	CcSEcCtD
Nelarabine—Loss of consciousness—Hydrocortisone—psoriasis	0.000575	0.000662	CcSEcCtD
Nelarabine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000575	0.000661	CcSEcCtD
Nelarabine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000574	0.00066	CcSEcCtD
Nelarabine—Anorexia—Cyclosporine—psoriasis	0.000572	0.000659	CcSEcCtD
Nelarabine—Convulsion—Hydrocortisone—psoriasis	0.000567	0.000652	CcSEcCtD
Nelarabine—Vomiting—Hydroxyurea—psoriasis	0.000564	0.000649	CcSEcCtD
Nelarabine—Anorexia—Mycophenolate mofetil—psoriasis	0.000558	0.000643	CcSEcCtD
Nelarabine—Myalgia—Hydrocortisone—psoriasis	0.000557	0.000641	CcSEcCtD
Nelarabine—Headache—Hydroxyurea—psoriasis	0.000555	0.000639	CcSEcCtD
Nelarabine—Connective tissue disorder—Prednisone—psoriasis	0.000549	0.000632	CcSEcCtD
Nelarabine—Hypotension—Mycophenolate mofetil—psoriasis	0.000547	0.00063	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000547	0.00063	CcSEcCtD
Nelarabine—Oedema—Prednisolone—psoriasis	0.000546	0.000629	CcSEcCtD
Nelarabine—Neutropenia—Methotrexate—psoriasis	0.000546	0.000628	CcSEcCtD
Nelarabine—Insomnia—Cyclosporine—psoriasis	0.000543	0.000625	CcSEcCtD
Nelarabine—Loss of consciousness—Triamcinolone—psoriasis	0.000541	0.000623	CcSEcCtD
Nelarabine—Paraesthesia—Cyclosporine—psoriasis	0.000539	0.000621	CcSEcCtD
Nelarabine—Cough—Triamcinolone—psoriasis	0.000537	0.000619	CcSEcCtD
Nelarabine—Dyspnoea—Cyclosporine—psoriasis	0.000535	0.000616	CcSEcCtD
Nelarabine—Somnolence—Cyclosporine—psoriasis	0.000534	0.000615	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000534	0.000614	CcSEcCtD
Nelarabine—Oedema—Hydrocortisone—psoriasis	0.000534	0.000614	CcSEcCtD
Nelarabine—Convulsion—Triamcinolone—psoriasis	0.000534	0.000614	CcSEcCtD
Nelarabine—Asthenia—Mycophenolic acid—psoriasis	0.000533	0.000613	CcSEcCtD
Nelarabine—Infection—Hydrocortisone—psoriasis	0.00053	0.00061	CcSEcCtD
Nelarabine—Insomnia—Mycophenolate mofetil—psoriasis	0.00053	0.00061	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000528	0.00484	CbGpPWpGaD
Nelarabine—Nausea—Hydroxyurea—psoriasis	0.000526	0.000606	CcSEcCtD
Nelarabine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000526	0.000606	CcSEcCtD
Nelarabine—Myalgia—Triamcinolone—psoriasis	0.000524	0.000604	CcSEcCtD
Nelarabine—Nervous system disorder—Hydrocortisone—psoriasis	0.000523	0.000603	CcSEcCtD
Nelarabine—Pneumonia—Methotrexate—psoriasis	0.000523	0.000603	CcSEcCtD
Nelarabine—Eye disorder—Prednisone—psoriasis	0.000522	0.000601	CcSEcCtD
Nelarabine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000522	0.000601	CcSEcCtD
Nelarabine—Decreased appetite—Cyclosporine—psoriasis	0.000522	0.000601	CcSEcCtD
Nelarabine—Somnolence—Mycophenolate mofetil—psoriasis	0.000521	0.0006	CcSEcCtD
Nelarabine—Infestation—Methotrexate—psoriasis	0.00052	0.000599	CcSEcCtD
Nelarabine—Infestation NOS—Methotrexate—psoriasis	0.00052	0.000599	CcSEcCtD
Nelarabine—Depression—Methotrexate—psoriasis	0.000519	0.000597	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000518	0.000597	CcSEcCtD
Nelarabine—Fatigue—Cyclosporine—psoriasis	0.000518	0.000596	CcSEcCtD
Nelarabine—Pain—Cyclosporine—psoriasis	0.000514	0.000591	CcSEcCtD
Nelarabine—Constipation—Cyclosporine—psoriasis	0.000514	0.000591	CcSEcCtD
Nelarabine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000509	0.000586	CcSEcCtD
Nelarabine—Anorexia—Hydrocortisone—psoriasis	0.000509	0.000586	CcSEcCtD
Nelarabine—Diarrhoea—Mycophenolic acid—psoriasis	0.000508	0.000585	CcSEcCtD
Nelarabine—Stomatitis—Methotrexate—psoriasis	0.000507	0.000584	CcSEcCtD
Nelarabine—Angiopathy—Prednisone—psoriasis	0.000507	0.000584	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000506	0.000582	CcSEcCtD
Nelarabine—Oedema—Triamcinolone—psoriasis	0.000503	0.000579	CcSEcCtD
Nelarabine—Constipation—Mycophenolate mofetil—psoriasis	0.000501	0.000577	CcSEcCtD
Nelarabine—Pain—Mycophenolate mofetil—psoriasis	0.000501	0.000577	CcSEcCtD
Nelarabine—Infection—Triamcinolone—psoriasis	0.000499	0.000575	CcSEcCtD
Nelarabine—Hypotension—Hydrocortisone—psoriasis	0.000499	0.000574	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—JUN—psoriasis	0.000497	0.00456	CbGpPWpGaD
Nelarabine—Feeling abnormal—Cyclosporine—psoriasis	0.000495	0.00057	CcSEcCtD
Nelarabine—Insomnia—Prednisolone—psoriasis	0.000494	0.000569	CcSEcCtD
Nelarabine—Hepatobiliary disease—Methotrexate—psoriasis	0.000492	0.000567	CcSEcCtD
Nelarabine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000491	0.000565	CcSEcCtD
Nelarabine—Loss of consciousness—Dexamethasone—psoriasis	0.000491	0.000565	CcSEcCtD
Nelarabine—Loss of consciousness—Betamethasone—psoriasis	0.000491	0.000565	CcSEcCtD
Nelarabine—Dizziness—Mycophenolic acid—psoriasis	0.000491	0.000565	CcSEcCtD
Nelarabine—Epistaxis—Methotrexate—psoriasis	0.000491	0.000565	CcSEcCtD
Nelarabine—Paraesthesia—Prednisolone—psoriasis	0.000491	0.000565	CcSEcCtD
Nelarabine—Mental disorder—Prednisone—psoriasis	0.00049	0.000564	CcSEcCtD
Nelarabine—Malnutrition—Prednisone—psoriasis	0.000487	0.00056	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000486	0.00056	CcSEcCtD
Nelarabine—Convulsion—Betamethasone—psoriasis	0.000484	0.000557	CcSEcCtD
Nelarabine—Convulsion—Dexamethasone—psoriasis	0.000484	0.000557	CcSEcCtD
Nelarabine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000483	0.000556	CcSEcCtD
Nelarabine—Insomnia—Hydrocortisone—psoriasis	0.000483	0.000556	CcSEcCtD
Nelarabine—Paraesthesia—Hydrocortisone—psoriasis	0.000479	0.000552	CcSEcCtD
Nelarabine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000479	0.000551	CcSEcCtD
Nelarabine—Myalgia—Dexamethasone—psoriasis	0.000476	0.000548	CcSEcCtD
Nelarabine—Myalgia—Betamethasone—psoriasis	0.000476	0.000548	CcSEcCtD
Nelarabine—Abdominal pain—Cyclosporine—psoriasis	0.000475	0.000547	CcSEcCtD
Nelarabine—Body temperature increased—Cyclosporine—psoriasis	0.000475	0.000547	CcSEcCtD
Nelarabine—Vomiting—Mycophenolic acid—psoriasis	0.000472	0.000543	CcSEcCtD
Nelarabine—DGUOK—Metabolism—APOE—psoriasis	0.00047	0.00431	CbGpPWpGaD
Nelarabine—Pain—Prednisolone—psoriasis	0.000467	0.000538	CcSEcCtD
Nelarabine—Headache—Mycophenolic acid—psoriasis	0.000465	0.000535	CcSEcCtD
Nelarabine—Decreased appetite—Hydrocortisone—psoriasis	0.000464	0.000534	CcSEcCtD
Nelarabine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000463	0.000533	CcSEcCtD
Nelarabine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000463	0.000533	CcSEcCtD
Nelarabine—Urinary tract disorder—Methotrexate—psoriasis	0.000461	0.000531	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000461	0.00053	CcSEcCtD
Nelarabine—Fatigue—Hydrocortisone—psoriasis	0.00046	0.00053	CcSEcCtD
Nelarabine—Vision blurred—Prednisone—psoriasis	0.000459	0.000528	CcSEcCtD
Nelarabine—Urethral disorder—Methotrexate—psoriasis	0.000458	0.000527	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000458	0.000527	CcSEcCtD
Nelarabine—Pain—Hydrocortisone—psoriasis	0.000456	0.000525	CcSEcCtD
Nelarabine—Oedema—Betamethasone—psoriasis	0.000456	0.000525	CcSEcCtD
Nelarabine—Oedema—Dexamethasone—psoriasis	0.000456	0.000525	CcSEcCtD
Nelarabine—Insomnia—Triamcinolone—psoriasis	0.000455	0.000523	CcSEcCtD
Nelarabine—Infection—Dexamethasone—psoriasis	0.000453	0.000522	CcSEcCtD
Nelarabine—Infection—Betamethasone—psoriasis	0.000453	0.000522	CcSEcCtD
Nelarabine—Paraesthesia—Triamcinolone—psoriasis	0.000451	0.000519	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisolone—psoriasis	0.00045	0.000518	CcSEcCtD
Nelarabine—Anaemia—Prednisone—psoriasis	0.00045	0.000518	CcSEcCtD
Nelarabine—Dyspnoea—Triamcinolone—psoriasis	0.000448	0.000516	CcSEcCtD
Nelarabine—Nervous system disorder—Dexamethasone—psoriasis	0.000447	0.000515	CcSEcCtD
Nelarabine—Nervous system disorder—Betamethasone—psoriasis	0.000447	0.000515	CcSEcCtD
Nelarabine—Thrombocytopenia—Betamethasone—psoriasis	0.000446	0.000514	CcSEcCtD
Nelarabine—Thrombocytopenia—Dexamethasone—psoriasis	0.000446	0.000514	CcSEcCtD
Nelarabine—Nausea—Mycophenolic acid—psoriasis	0.000441	0.000508	CcSEcCtD
Nelarabine—Feeling abnormal—Hydrocortisone—psoriasis	0.00044	0.000506	CcSEcCtD
Nelarabine—Eye disorder—Methotrexate—psoriasis	0.000437	0.000503	CcSEcCtD
Nelarabine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000436	0.000502	CcSEcCtD
Nelarabine—Anorexia—Betamethasone—psoriasis	0.000435	0.0005	CcSEcCtD
Nelarabine—Anorexia—Dexamethasone—psoriasis	0.000435	0.0005	CcSEcCtD
Nelarabine—Cardiac disorder—Methotrexate—psoriasis	0.000434	0.000499	CcSEcCtD
Nelarabine—Fatigue—Triamcinolone—psoriasis	0.000433	0.000499	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—psoriasis	0.000433	0.00398	CbGpPWpGaD
Nelarabine—Asthenia—Cyclosporine—psoriasis	0.000431	0.000496	CcSEcCtD
Nelarabine—Pain—Triamcinolone—psoriasis	0.00043	0.000495	CcSEcCtD
Nelarabine—DCK—Levonorgestrel—Hydrocortisone—psoriasis	0.000429	0.0191	CbGdCrCtD
Nelarabine—Loss of consciousness—Prednisone—psoriasis	0.000428	0.000492	CcSEcCtD
Nelarabine—Hypotension—Betamethasone—psoriasis	0.000426	0.000491	CcSEcCtD
Nelarabine—Hypotension—Dexamethasone—psoriasis	0.000426	0.000491	CcSEcCtD
Nelarabine—Angiopathy—Methotrexate—psoriasis	0.000424	0.000488	CcSEcCtD
Nelarabine—Body temperature increased—Hydrocortisone—psoriasis	0.000422	0.000486	CcSEcCtD
Nelarabine—Abdominal pain—Hydrocortisone—psoriasis	0.000422	0.000486	CcSEcCtD
Nelarabine—Convulsion—Prednisone—psoriasis	0.000422	0.000485	CcSEcCtD
Nelarabine—Mediastinal disorder—Methotrexate—psoriasis	0.000421	0.000485	CcSEcCtD
Nelarabine—Asthenia—Mycophenolate mofetil—psoriasis	0.00042	0.000484	CcSEcCtD
Nelarabine—Chills—Methotrexate—psoriasis	0.000419	0.000483	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000415	0.000478	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000415	0.000478	CcSEcCtD
Nelarabine—Arthralgia—Prednisone—psoriasis	0.000414	0.000477	CcSEcCtD
Nelarabine—Myalgia—Prednisone—psoriasis	0.000414	0.000477	CcSEcCtD
Nelarabine—Feeling abnormal—Triamcinolone—psoriasis	0.000414	0.000477	CcSEcCtD
Nelarabine—Insomnia—Dexamethasone—psoriasis	0.000412	0.000475	CcSEcCtD
Nelarabine—Insomnia—Betamethasone—psoriasis	0.000412	0.000475	CcSEcCtD
Nelarabine—Diarrhoea—Cyclosporine—psoriasis	0.000411	0.000473	CcSEcCtD
Nelarabine—Paraesthesia—Dexamethasone—psoriasis	0.000409	0.000471	CcSEcCtD
Nelarabine—Paraesthesia—Betamethasone—psoriasis	0.000409	0.000471	CcSEcCtD
Nelarabine—Mental disorder—Methotrexate—psoriasis	0.000409	0.000471	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PPARG—psoriasis	0.000409	0.00375	CbGpPWpGaD
Nelarabine—Malnutrition—Methotrexate—psoriasis	0.000407	0.000468	CcSEcCtD
Nelarabine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000401	0.000461	CcSEcCtD
Nelarabine—Dysgeusia—Methotrexate—psoriasis	0.000398	0.000458	CcSEcCtD
Nelarabine—Body temperature increased—Triamcinolone—psoriasis	0.000397	0.000457	CcSEcCtD
Nelarabine—Dizziness—Cyclosporine—psoriasis	0.000397	0.000457	CcSEcCtD
Nelarabine—Oedema—Prednisone—psoriasis	0.000397	0.000457	CcSEcCtD
Nelarabine—Decreased appetite—Dexamethasone—psoriasis	0.000396	0.000456	CcSEcCtD
Nelarabine—Decreased appetite—Betamethasone—psoriasis	0.000396	0.000456	CcSEcCtD
Nelarabine—Infection—Prednisone—psoriasis	0.000395	0.000454	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000394	0.000453	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000394	0.000453	CcSEcCtD
Nelarabine—Back pain—Methotrexate—psoriasis	0.000393	0.000453	CcSEcCtD
Nelarabine—Fatigue—Dexamethasone—psoriasis	0.000393	0.000453	CcSEcCtD
Nelarabine—Fatigue—Betamethasone—psoriasis	0.000393	0.000453	CcSEcCtD
Nelarabine—Pain—Dexamethasone—psoriasis	0.00039	0.000449	CcSEcCtD
Nelarabine—Pain—Betamethasone—psoriasis	0.00039	0.000449	CcSEcCtD
Nelarabine—Nervous system disorder—Prednisone—psoriasis	0.000389	0.000448	CcSEcCtD
Nelarabine—Dizziness—Mycophenolate mofetil—psoriasis	0.000387	0.000446	CcSEcCtD
Nelarabine—Vision blurred—Methotrexate—psoriasis	0.000383	0.000441	CcSEcCtD
Nelarabine—Asthenia—Hydrocortisone—psoriasis	0.000383	0.000441	CcSEcCtD
Nelarabine—Vomiting—Cyclosporine—psoriasis	0.000382	0.00044	CcSEcCtD
Nelarabine—Anorexia—Prednisone—psoriasis	0.000379	0.000436	CcSEcCtD
Nelarabine—Headache—Cyclosporine—psoriasis	0.000376	0.000433	CcSEcCtD
Nelarabine—Anaemia—Methotrexate—psoriasis	0.000376	0.000433	CcSEcCtD
Nelarabine—Feeling abnormal—Dexamethasone—psoriasis	0.000376	0.000433	CcSEcCtD
Nelarabine—Feeling abnormal—Betamethasone—psoriasis	0.000376	0.000433	CcSEcCtD
Nelarabine—Gastrointestinal pain—Betamethasone—psoriasis	0.000373	0.000429	CcSEcCtD
Nelarabine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000373	0.000429	CcSEcCtD
Nelarabine—Vomiting—Mycophenolate mofetil—psoriasis	0.000372	0.000429	CcSEcCtD
Nelarabine—Headache—Mycophenolate mofetil—psoriasis	0.000367	0.000423	CcSEcCtD
Nelarabine—Diarrhoea—Hydrocortisone—psoriasis	0.000365	0.00042	CcSEcCtD
Nelarabine—Leukopenia—Methotrexate—psoriasis	0.000364	0.000419	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000362	0.000417	CcSEcCtD
Nelarabine—Dizziness—Prednisolone—psoriasis	0.000361	0.000416	CcSEcCtD
Nelarabine—Asthenia—Triamcinolone—psoriasis	0.000361	0.000415	CcSEcCtD
Nelarabine—Abdominal pain—Dexamethasone—psoriasis	0.00036	0.000415	CcSEcCtD
Nelarabine—Body temperature increased—Dexamethasone—psoriasis	0.00036	0.000415	CcSEcCtD
Nelarabine—Body temperature increased—Betamethasone—psoriasis	0.00036	0.000415	CcSEcCtD
Nelarabine—Abdominal pain—Betamethasone—psoriasis	0.00036	0.000415	CcSEcCtD
Nelarabine—Insomnia—Prednisone—psoriasis	0.000359	0.000413	CcSEcCtD
Nelarabine—Nausea—Cyclosporine—psoriasis	0.000357	0.000411	CcSEcCtD
Nelarabine—Paraesthesia—Prednisone—psoriasis	0.000357	0.000411	CcSEcCtD
Nelarabine—Cough—Methotrexate—psoriasis	0.000355	0.000409	CcSEcCtD
Nelarabine—Dizziness—Hydrocortisone—psoriasis	0.000353	0.000406	CcSEcCtD
Nelarabine—Convulsion—Methotrexate—psoriasis	0.000352	0.000406	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.00035	0.00321	CbGpPWpGaD
Nelarabine—Nausea—Mycophenolate mofetil—psoriasis	0.000348	0.000401	CcSEcCtD
Nelarabine—Chest pain—Methotrexate—psoriasis	0.000346	0.000399	CcSEcCtD
Nelarabine—Myalgia—Methotrexate—psoriasis	0.000346	0.000399	CcSEcCtD
Nelarabine—Arthralgia—Methotrexate—psoriasis	0.000346	0.000399	CcSEcCtD
Nelarabine—Decreased appetite—Prednisone—psoriasis	0.000345	0.000397	CcSEcCtD
Nelarabine—Fatigue—Prednisone—psoriasis	0.000342	0.000394	CcSEcCtD
Nelarabine—Headache—Prednisolone—psoriasis	0.000342	0.000394	CcSEcCtD
Nelarabine—Constipation—Prednisone—psoriasis	0.00034	0.000391	CcSEcCtD
Nelarabine—Vomiting—Hydrocortisone—psoriasis	0.000339	0.000391	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000337	0.00309	CbGpPWpGaD
Nelarabine—Confusional state—Methotrexate—psoriasis	0.000335	0.000385	CcSEcCtD
Nelarabine—Headache—Hydrocortisone—psoriasis	0.000334	0.000385	CcSEcCtD
Nelarabine—Dizziness—Triamcinolone—psoriasis	0.000332	0.000383	CcSEcCtD
Nelarabine—Infection—Methotrexate—psoriasis	0.00033	0.00038	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—TP53—psoriasis	0.000328	0.00301	CbGpPWpGaD
Nelarabine—Feeling abnormal—Prednisone—psoriasis	0.000327	0.000377	CcSEcCtD
Nelarabine—Asthenia—Betamethasone—psoriasis	0.000327	0.000377	CcSEcCtD
Nelarabine—Asthenia—Dexamethasone—psoriasis	0.000327	0.000377	CcSEcCtD
Nelarabine—ADA—Metabolism—CARM1—psoriasis	0.000326	0.00299	CbGpPWpGaD
Nelarabine—Nervous system disorder—Methotrexate—psoriasis	0.000325	0.000375	CcSEcCtD
Nelarabine—Thrombocytopenia—Methotrexate—psoriasis	0.000325	0.000374	CcSEcCtD
Nelarabine—Gastrointestinal pain—Prednisone—psoriasis	0.000325	0.000374	CcSEcCtD
Nelarabine—Nausea—Prednisolone—psoriasis	0.000325	0.000374	CcSEcCtD
Nelarabine—Vomiting—Triamcinolone—psoriasis	0.00032	0.000368	CcSEcCtD
Nelarabine—Nausea—Hydrocortisone—psoriasis	0.000317	0.000365	CcSEcCtD
Nelarabine—Anorexia—Methotrexate—psoriasis	0.000316	0.000364	CcSEcCtD
Nelarabine—Headache—Triamcinolone—psoriasis	0.000315	0.000362	CcSEcCtD
Nelarabine—Abdominal pain—Prednisone—psoriasis	0.000314	0.000361	CcSEcCtD
Nelarabine—Body temperature increased—Prednisone—psoriasis	0.000314	0.000361	CcSEcCtD
Nelarabine—Diarrhoea—Dexamethasone—psoriasis	0.000312	0.000359	CcSEcCtD
Nelarabine—Diarrhoea—Betamethasone—psoriasis	0.000312	0.000359	CcSEcCtD
Nelarabine—Hypotension—Methotrexate—psoriasis	0.00031	0.000357	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000306	0.00281	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PCNA—psoriasis	0.000304	0.00279	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000302	0.000348	CcSEcCtD
Nelarabine—Dizziness—Betamethasone—psoriasis	0.000302	0.000347	CcSEcCtD
Nelarabine—Dizziness—Dexamethasone—psoriasis	0.000302	0.000347	CcSEcCtD
Nelarabine—DCK—Metabolism—CARM1—psoriasis	0.000301	0.00276	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—psoriasis	0.0003	0.00276	CbGpPWpGaD
Nelarabine—Insomnia—Methotrexate—psoriasis	0.0003	0.000346	CcSEcCtD
Nelarabine—Nausea—Triamcinolone—psoriasis	0.000299	0.000344	CcSEcCtD
Nelarabine—Paraesthesia—Methotrexate—psoriasis	0.000298	0.000343	CcSEcCtD
Nelarabine—Dyspnoea—Methotrexate—psoriasis	0.000296	0.000341	CcSEcCtD
Nelarabine—Somnolence—Methotrexate—psoriasis	0.000295	0.00034	CcSEcCtD
Nelarabine—Vomiting—Dexamethasone—psoriasis	0.00029	0.000334	CcSEcCtD
Nelarabine—Vomiting—Betamethasone—psoriasis	0.00029	0.000334	CcSEcCtD
Nelarabine—Decreased appetite—Methotrexate—psoriasis	0.000289	0.000332	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000287	0.00033	CcSEcCtD
Nelarabine—Fatigue—Methotrexate—psoriasis	0.000286	0.000329	CcSEcCtD
Nelarabine—Headache—Dexamethasone—psoriasis	0.000286	0.000329	CcSEcCtD
Nelarabine—Headache—Betamethasone—psoriasis	0.000286	0.000329	CcSEcCtD
Nelarabine—Asthenia—Prednisone—psoriasis	0.000285	0.000328	CcSEcCtD
Nelarabine—Pain—Methotrexate—psoriasis	0.000284	0.000327	CcSEcCtD
Nelarabine—Feeling abnormal—Methotrexate—psoriasis	0.000273	0.000315	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—PCNA—psoriasis	0.000272	0.0025	CbGpPWpGaD
Nelarabine—Diarrhoea—Prednisone—psoriasis	0.000272	0.000313	CcSEcCtD
Nelarabine—Gastrointestinal pain—Methotrexate—psoriasis	0.000271	0.000312	CcSEcCtD
Nelarabine—Nausea—Betamethasone—psoriasis	0.000271	0.000312	CcSEcCtD
Nelarabine—Nausea—Dexamethasone—psoriasis	0.000271	0.000312	CcSEcCtD
Nelarabine—Dizziness—Prednisone—psoriasis	0.000263	0.000302	CcSEcCtD
Nelarabine—Body temperature increased—Methotrexate—psoriasis	0.000262	0.000302	CcSEcCtD
Nelarabine—Abdominal pain—Methotrexate—psoriasis	0.000262	0.000302	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.000262	0.0024	CbGpPWpGaD
Nelarabine—Vomiting—Prednisone—psoriasis	0.000252	0.000291	CcSEcCtD
Nelarabine—Headache—Prednisone—psoriasis	0.000249	0.000286	CcSEcCtD
Nelarabine—Asthenia—Methotrexate—psoriasis	0.000238	0.000274	CcSEcCtD
Nelarabine—Nausea—Prednisone—psoriasis	0.000236	0.000272	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.000231	0.00212	CbGpPWpGaD
Nelarabine—Diarrhoea—Methotrexate—psoriasis	0.000227	0.000261	CcSEcCtD
Nelarabine—Dizziness—Methotrexate—psoriasis	0.000219	0.000253	CcSEcCtD
Nelarabine—Vomiting—Methotrexate—psoriasis	0.000211	0.000243	CcSEcCtD
Nelarabine—Headache—Methotrexate—psoriasis	0.000208	0.000239	CcSEcCtD
Nelarabine—ADA—Metabolism—CAT—psoriasis	0.000201	0.00184	CbGpPWpGaD
Nelarabine—Nausea—Methotrexate—psoriasis	0.000197	0.000227	CcSEcCtD
Nelarabine—DCK—Metabolism—CAT—psoriasis	0.000185	0.0017	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOE—psoriasis	0.000156	0.00143	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOE—psoriasis	0.000144	0.00132	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—psoriasis	0.000136	0.00125	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—psoriasis	0.000125	0.00115	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—psoriasis	0.0001	0.000918	CbGpPWpGaD
